Last reviewed · How we verify
Identification of Risk Factors Parkinson's Disease by Convergence Strategy (CONVERGENCE)
Using this convergence approach from a limited group of subjects with non-diseased controls, patients with Parkinson's disease or related diseases, we will be able to limit the number of potential genes of specific susceptibility to Parkinson disease. These genes will then be studied using a case-control genetic epidemiology approach. The risk of developing the disease will then be evaluated according to clinical, biological and environmental variables collected in Parkinson's subjects and healthy controls in the second group of subjects. The specificity of the genetic associations found will be evaluated in subjects with Parkinson's disease.
Details
| Lead sponsor | University Hospital, Lille |
|---|---|
| Status | COMPLETED |
| Enrolment | 2220 |
| Start date | Wed Mar 25 2009 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Tue Nov 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Parkinson Disease
Countries
France